Table 2.
Baseline characteristics
| Parameters | TNBC patients (N=179) |
|---|---|
| Age (years) | 45.9±6.1 |
| BMI (kg/m2) | 23.3±2.0 |
| Obesity (n/%) | 35 (19.6) |
| Smoke (n/%) | 32 (17.9) |
| Hypertension (n/%) | 41 (22.9) |
| Diabetes mellitus (n/%) | 8 (4.5) |
| Dyslipidemia (n/%) | 32 (17.9) |
| Hyperuricemia (n/%) | 31 (17.3) |
| Chromic kidney disease (n/%) | 4 (2.2) |
| Pathological grade (n/%) | |
| Grade 1 | 44 (24.6) |
| Grade 2 | 117 (65.3) |
| Grade 3 | 18 (10.1) |
| Tumor size (cm) | 3.0 (2.2-4.0) |
| T stage (n/%) | |
| T1 | 34 (19.0) |
| T2 | 135 (75.4) |
| T3 | 10 (5.6) |
| N stage (n/%) | |
| N0 | 79 (44.1) |
| N1 | 68 (38.0) |
| N2 | 32 (17.9) |
| TNM stage (n/%) | |
| II | 145 (81.0) |
| III | 34 (19.0) |
| ECOG performance (n/%) | |
| 0 | 138 (77.1) |
| 1 | 41 (22.9) |
| LVEF (%) | 67.0 (64.0-71.0) |
| cTnI (ng/mL) | 0.021 (0.010-0.049) |
| NT-proBNP (ng/mL) | 0.076 (0.060-0.096) |
Data were presented as the mean ± standard deviation, count (%) or median (25th-75th quantiles). Obesity was defined as BMI ≥25 kg/m2. TNBC, triple-negative breast cancer; BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; LVEF, left ventricular ejection fraction; cTnI, cardiac troponin I; NT-proBNP, N-terminal pro brain natriuretic peptide.